Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 36 articles: HTML format

Single Articles

June 2021
1. AWAD MM, Liu S, Rybkin II, Arbour KC, et al
   Acquired Resistance to KRAS(G12C) Inhibition in Cancer.
   N Engl J Med. 2021;384:2382-2393.
   PubMed     Abstract available
   
   
   March 2021
2. ROUSSEAU B, Foote MB, Maron SB, Diplas BH, et al
   The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors.
   N Engl J Med. 2021;384:1168-1170.
   PubMed    
   
   
   
3. DIAZ LA JR, Le DT, Andre T
   Microsatellite-Instability-High Advanced Colorectal Cancer. Reply.
   N Engl J Med. 2021;384:972-973.
   PubMed    
   
   
   
4. SORSCHER S
   Microsatellite-Instability-High Advanced Colorectal Cancer.
   N Engl J Med. 2021;384:972.
   PubMed    
   
   
   
5. BATTISTUZZI L, Puccini A, Sciallero S
   Microsatellite-Instability-High Advanced Colorectal Cancer.
   N Engl J Med. 2021;384:971-972.
   PubMed    
   
   
   December 2020
6. GROTHEY A
   Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care.
   N Engl J Med. 2020;383:2283-2285.
   PubMed    
   
   
   
7. ANDRE T, Shiu KK, Kim TW, Jensen BV, et al
   Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
   N Engl J Med. 2020;383:2207-2218.
   PubMed     Abstract available
   
   
   November 2020
8. LU KH, Broaddus RR
   Endometrial Cancer.
   N Engl J Med. 2020;383:2053-2064.
   PubMed    
   
   
   September 2020
9. HONG DS, Fakih MG, Strickler JH, Desai J, et al
   KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors.
   N Engl J Med. 2020;383:1207-1217.
   PubMed     Abstract available
   
   
   
10. BURKE CA, Dekker E, Lynch P, Samadder NJ, et al
    Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
    N Engl J Med. 2020;383:1028-1039.
    PubMed     Abstract available
    
    
    August 2020
11. KHANNA S, Sengupta T
    Oral Metastasis of Colorectal Cancer.
    N Engl J Med. 2020;383:e47.
    PubMed    
    
    
    July 2020
12. SHEHADEH M, Oweis E
    Silver Stool.
    N Engl J Med. 2020;383:261.
    PubMed    
    
    
    
13. ODIO CD, O'Brien CR, Jacox J, Jain D, et al
    Cryptic Cachexia.
    N Engl J Med. 2020;383:68-74.
    PubMed    
    
    
    June 2020
14. RANDALL G, Abrahams J
    Cutaneous Colon Cancer Metastases in a Surgical Scar.
    N Engl J Med. 2020;382:e90.
    PubMed    
    
    
    February 2020
15. KOPETZ S, Grothey A, Tabernero J
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply.
    N Engl J Med. 2020;382:877-878.
    PubMed    
    
    
    
16. PIETRANTONIO F
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    N Engl J Med. 2020;382:876-877.
    PubMed    
    
    
    
17. PRASAD V
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    N Engl J Med. 2020;382:876.
    PubMed    
    
    
    
18. SHARMA V, Vanidassane I
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    N Engl J Med. 2020;382:876.
    PubMed    
    
    
    January 2020
19. SCHAEFER JK, Ramnath N
    Fluorouracil-Induced Hyperpigmentation.
    N Engl J Med. 2020;382:e6.
    PubMed    
    
    
    September 2019
20. KOPETZ S, Grothey A, Yaeger R, Van Cutsem E, et al
    Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    N Engl J Med. 2019 Sep 30. doi: 10.1056/NEJMoa1908075.
    PubMed     Abstract available
    
    
    January 2019
21. PROUTY M, Liu D
    Erythema Gyratum Repens Associated with Anal Cancer.
    N Engl J Med. 2019;380:e3.
    PubMed    
    
    
    December 2018
22. COEBERGH VAN DEN BRAAK RRJ, Martens JWM, Ijzermans JNM
    Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer".
    N Engl J Med. 2018;379:2481.
    PubMed    
    
    
    October 2018
23. MURPHY JE, Shampain K, Riley LE, Clark JW, et al
    Case 32-2018: A 36-Year-Old Pregnant Woman with Newly Diagnosed Adenocarcinoma.
    N Engl J Med. 2018;379:1562-1570.
    PubMed    
    
    
    September 2018
24. RUBIN AK, Burk KS, Staller K, Kunitake H, et al
    Case 30-2018: A 66-Year-Old Woman with Chronic Abdominal Pain.
    N Engl J Med. 2018;379:1263-1272.
    PubMed    
    
    
    August 2018
25. DRAZEN JM
    Life Lessons from Paul in the Face of Death.
    N Engl J Med. 2018;379:808-809.
    PubMed    
    
    
    
26. SINICROPE FA
    Lynch Syndrome-Associated Colorectal Cancer.
    N Engl J Med. 2018;379:764-773.
    PubMed    
    
    
    July 2018
27. CHEN G, Li J
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med. 2018;379:395-6.
    PubMed    
    
    
    
28. RAMOS-ESQUIVEL A
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med. 2018;379:395.
    PubMed    
    
    
    
29. 
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med. 2018;379:395-397.
    PubMed    
    
    
    
30. BAGLIONI P
    The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018;379:301.
    PubMed    
    
    
    
31. 
    The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018;379:301-302.
    PubMed    
    
    
    April 2018
32. CHEN PY
    Colon Cutoff Sign.
    N Engl J Med. 2018;378:1621.
    PubMed    
    
    
    March 2018
33. GROTHEY A, Sobrero AF, Shields AF, Yoshino T, et al
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med. 2018;378:1177-1188.
    PubMed     Abstract available
    
    
    
34. SCHILSKY RL
    A New IDEA in Adjuvant Chemotherapy for Colon Cancer.
    N Engl J Med. 2018;378:1242-1244.
    PubMed    
    
    
    
35. LAUBY-SECRETAN B, Vilahur N, Bianchini F, Guha N, et al
    The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018 Mar 26. doi: 10.1056/NEJMsr1714643.
    PubMed    
    
    
    October 2017
36. LEMERY S, Keegan P, Pazdur R
    First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
    N Engl J Med. 2017;377:1409-1412.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: